Silence Therapeutics plc
SLNCF
$2.00
$0.2514.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.77M | -20.96M | -27.35M | -28.53M | 12.30M |
| Total Depreciation and Amortization | 113.00K | 156.00K | 148.00K | 138.00K | 140.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -736.00K | 848.00K | 9.92M | 5.59M | -9.19M |
| Change in Net Operating Assets | -4.89M | 9.06M | -4.50M | 10.49M | -30.73M |
| Cash from Operations | -17.29M | -10.89M | -21.78M | -12.31M | -27.48M |
| Capital Expenditure | 0.00 | -3.00K | -48.00K | -4.00K | -62.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.34M | 51.29M | -1.51M | -44.38M | 66.19M |
| Cash from Investing | -53.34M | 51.29M | -1.56M | -44.38M | 66.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 1.00K | 14.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -98.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 1.00K | 14.00K | -98.00K |
| Foreign Exchange rate Adjustments | -129.00K | -106.00K | 198.00K | 232.00K | -159.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.75M | 40.29M | -23.15M | -56.44M | 38.39M |